Patient Stories
The following content discusses the Trans-Arterial Micro-Perfusion (TAMP™) therapy platform, which is enabled by the FDA-cleared RenovoCath. RenovoCath is indicated for temporary vessel occlusion in applications including arteriography, preoperative occlusion, and chemotherapeutic drug infusion.
RenovoRx is evaluating the use of TAMP with gemcitabine as a combination product (known as intra-arterial gemcitabine) for the treatment of locally advanced pancreatic cancer (LAPC), including in the ongoing Phase III TIGeR-PaC trial, under a U.S. Investigational New Drug Application. Ongoing clinical studies continue to evaluate safety and clinical outcomes in patients with LAPC. For RenovoCath’s Indications for Use and safety information, please visit IFU-10004-Rev.-G-Universal-IFU.pdf.
Learn more about patient experiences with the TAMP therapy platform
New Cancer Tech Sends Chemo Straight To Tumors
A targeted drug-delivery device may help some pancreatic cancer patients get chemotherapy with fewer body-wide side effects.
New Device Delivers Targeted Chemo for Pancreatic Cancer, Offering Fresh Hope
For 70-year-old Roberta Luna, tending to her garden is therapy — especially trimming rosemary, its purple blooms matching the color she wears every day for pancreatic cancer awareness: purple.
Jersey Shore Hospital Offering New Treatment to Target Pancreatic Cancer
Pancreatic cancer is a disease that’s often deadly, but a new treatment is showing promise at a New Jersey hospital. NBC10’s Ted Greenberg explains how it has made a difference for one man who thought he was out of options.
Moffitt Using New Approach to Treat Pancreatic Cancer
When 83-year-old Richard Martin was diagnosed with pancreatic cancer in 2024, he underwent 22 rounds of chemotherapy followed by radiation.
Doctors Testing 'Groundbreaking' Treatment for Pancreatic Cancer
A new treatment for pancreatic cancer is being tested out in clinical trials in several states, and one North Carolina doctor called it "groundbreaking."
Lakewood Ranch Pancreatic Cancer Patient Receives New Treatment
A Lakewood Ranch retiree is one of the first patients in the country to receive an experimental treatment for pancreatic cancer through a trial offered at Sarasota Memorial Hospital.
Take the Next Step
Your doctor will determine if TAMP is right for you and how this approach may fit within your overall treatment plan.
